286 related articles for article (PubMed ID: 26300392)
1. α2-Adrenergic modulation of the glutamate receptor and transporter function in a chronic ocular hypertension model.
Jung KI; Kim JH; Park CK
Eur J Pharmacol; 2015 Oct; 765():274-83. PubMed ID: 26300392
[TBL] [Abstract][Full Text] [Related]
2. Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity.
Dong CJ; Guo Y; Agey P; Wheeler L; Hare WA
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4515-22. PubMed ID: 18566471
[TBL] [Abstract][Full Text] [Related]
3. Brimonidine enhances inhibitory postsynaptic activity of OFF- and ON-type retinal ganglion cells in a Wistar rat chronic glaucoma model.
Zhou X; Zhang T; Wu J
Exp Eye Res; 2019 Dec; 189():107833. PubMed ID: 31618613
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension.
WoldeMussie E; Ruiz G; Wijono M; Wheeler LA
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2849-55. PubMed ID: 11687528
[TBL] [Abstract][Full Text] [Related]
5. Alteration of retinal intrinsic survival signal and effect of alpha2-adrenergic receptor agonist in the retina of the chronic ocular hypertension rat.
Kim HS; Chang YI; Kim JH; Park CK
Vis Neurosci; 2007; 24(2):127-39. PubMed ID: 17640403
[TBL] [Abstract][Full Text] [Related]
6. Brimonidine blocks glutamate excitotoxicity-induced oxidative stress and preserves mitochondrial transcription factor a in ischemic retinal injury.
Lee D; Kim KY; Noh YH; Chai S; Lindsey JD; Ellisman MH; Weinreb RN; Ju WK
PLoS One; 2012; 7(10):e47098. PubMed ID: 23056591
[TBL] [Abstract][Full Text] [Related]
7. Alpha-2 adrenergic receptor agonists are neuroprotective in experimental models of glaucoma.
Wheeler LA; Woldemussie E
Eur J Ophthalmol; 2001; 11 Suppl 2():S30-5. PubMed ID: 11592528
[TBL] [Abstract][Full Text] [Related]
8. Melatonin and its analog 5-methoxycarbonylamino-N-acetyltryptamine potentiate adrenergic receptor-mediated ocular hypotensive effects in rabbits: significance for combination therapy in glaucoma.
Crooke A; Huete-Toral F; Martínez-Águila A; Martín-Gil A; Pintor J
J Pharmacol Exp Ther; 2013 Jul; 346(1):138-45. PubMed ID: 23591996
[TBL] [Abstract][Full Text] [Related]
9. Neurochemical evidence to implicate elevated glutamate in the mechanisms of high intraocular pressure (IOP)-induced retinal ganglion cell death in rat.
Nucci C; Tartaglione R; Rombolà L; Morrone LA; Fazzi E; Bagetta G
Neurotoxicology; 2005 Oct; 26(5):935-41. PubMed ID: 16126273
[TBL] [Abstract][Full Text] [Related]
10. Nimodipine enhancement of alpha2 adrenergic modulation of NMDA receptor via a mechanism independent of Ca2+ channel blocking.
Dong CJ; Guo Y; Agey P; Wheeler L; Hare WA
Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4174-80. PubMed ID: 20335610
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the neuroprotective effects of brimonidine tartrate and melatonin on retinal ganglion cells.
Marangoz D; Guzel E; Eyuboglu S; Gumusel A; Seckin I; Ciftci F; Yilmaz B; Yalvac I
Int Ophthalmol; 2018 Dec; 38(6):2553-2562. PubMed ID: 29159432
[TBL] [Abstract][Full Text] [Related]
12. Vitreous and aqueous concentrations of brimonidine following topical application of brimonidine tartrate 0.1% ophthalmic solution in humans.
Takamura Y; Tomomatsu T; Matsumura T; Takihara Y; Kozai S; Arimura S; Yokota S; Inatani M
J Ocul Pharmacol Ther; 2015 Jun; 31(5):282-5. PubMed ID: 25918904
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effect of alpha(2) agonist (brimonidine) on adult rat retinal ganglion cells after increased intraocular pressure.
Ahmed FA; Hegazy K; Chaudhary P; Sharma SC
Brain Res; 2001 Sep; 913(2):133-9. PubMed ID: 11549376
[TBL] [Abstract][Full Text] [Related]
14. Glutamate receptor activation triggers OPA1 release and induces apoptotic cell death in ischemic rat retina.
Ju WK; Lindsey JD; Angert M; Patel A; Weinreb RN
Mol Vis; 2008; 14():2629-38. PubMed ID: 19122832
[TBL] [Abstract][Full Text] [Related]
15. Alpha2-adrenergic receptors and their core involvement in the process of axonal growth in retinal explants.
Prokosch V; Panagis L; Volk GF; Dermon C; Thanos S
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6688-99. PubMed ID: 20592227
[TBL] [Abstract][Full Text] [Related]
16. Prevention of retinal ganglion cell swelling by systemic brimonidine in a rat experimental glaucoma model.
Pinar-Sueiro S; Urcola H; Rivas MA; Vecino E
Clin Exp Ophthalmol; 2011 Nov; 39(8):799-807. PubMed ID: 21631673
[TBL] [Abstract][Full Text] [Related]
17. Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments.
Hernández M; Urcola JH; Vecino E
Exp Eye Res; 2008 May; 86(5):798-806. PubMed ID: 18394603
[TBL] [Abstract][Full Text] [Related]
18. Detection of early neuron degeneration and accompanying glial responses in the visual pathway in a rat model of acute intraocular hypertension.
Zhang S; Wang H; Lu Q; Qing G; Wang N; Wang Y; Li S; Yang D; Yan F
Brain Res; 2009 Dec; 1303():131-43. PubMed ID: 19765568
[TBL] [Abstract][Full Text] [Related]
19. Brimonidine: a new alpha2-adrenoreceptor agonist for glaucoma treatment.
Greenfield DS; Liebmann JM; Ritch R
J Glaucoma; 1997 Aug; 6(4):250-8. PubMed ID: 9264305
[TBL] [Abstract][Full Text] [Related]
20. Role of retinal glial cell glutamate transporters in retinal ganglion cell survival following stimulation of NMDA receptor.
Furuya T; Pan Z; Kashiwagi K
Curr Eye Res; 2012 Mar; 37(3):170-8. PubMed ID: 22335803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
